Sweet Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$608K Sell
5,354
-2,514
-32% -$299K 0.13% 115
2024
Q2
$974K Sell
7,868
-2,451
-24% -$316K 0.22% 77
2024
Q1
$1.36M Sell
10,319
-12,973
-56% -$1.6M 0.31% 69
2023
Q4
$2.54M Buy
23,292
+2,837
+14% +$294K 0.6% 33
2023
Q3
$2.11M Buy
20,455
+1,292
+7% +$139K 0.56% 33
2023
Q2
$2.21M Buy
19,163
+3,037
+19% +$345K 0.58% 32
2023
Q1
$1.72M Buy
16,126
+2,411
+18% +$260K 0.47% 36
2022
Q4
$1.52M Buy
13,715
+993
+8% +$102K 0.45% 32
2022
Q3
$1.1M Buy
12,722
+6,507
+105% +$581K 0.35% 41
2022
Q2
$567K Sell
6,215
-208
-3% -$18.4K 0.18% 78
2022
Q1
$527K Buy
6,423
+153
+2% +$12.1K 0.14% 94
2021
Q4
$481K Buy
+6,270
New +$499K 0.2% 71

Other funds holding MRK

Sweet Financial Partners's MRK Position: Q3 2024 in Review

Sweet Financial Partners reduced its Merck (MRK) stake by 32% in Q3 2024, selling an estimated $299K and leaving 5,354 shares worth $608K. The position accounts for 0.13% of the portfolio, ranked #115.

Sweet Financial Partners first reported a position in MRK in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.54M in Q4 2023. 3,496 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Sweet Financial Partners held 5,354 shares of Merck worth $608K as of Q3 2024.
  • Sweet Financial Partners sold 2,514 Merck shares in Q3 2024, an estimated $299K.
  • Merck made up 0.13% of Sweet Financial Partners's portfolio in Q3 2024, its #115 holding.
  • Sweet Financial Partners first reported a position in Merck in Q4 2021 and has held it in 12 quarters since.
  • Sweet Financial Partners's Merck position peaked at $2.54M in Q4 2023.
  • 3,496 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Sweet Financial Partners's 13F filing for Q3 2024, filed 16 Oct 2024.